ArticleCPT: pharmacometrics & systems pharmacology2025

Population Pharmacokinetic Analysis of Datopotamab Deruxtecan (Dato-DXd), a TROP2-Directed Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors.

Ying Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.